2022 Q3 Form 10-Q Financial Statement
#000101738622000361 Filed on August 15, 2022
Income Statement
Concept | 2022 Q3 | 2022 Q2 | 2021 Q4 |
---|---|---|---|
Revenue | $8.525K | $7.803K | $4.500K |
YoY Change | 27.62% | -17.71% | |
Cost Of Revenue | $2.275K | $2.068K | $1.310K |
YoY Change | 8.33% | -18.39% | |
Gross Profit | $6.250K | $5.735K | $3.190K |
YoY Change | 36.46% | -17.46% | |
Gross Profit Margin | 73.31% | 73.5% | 70.89% |
Selling, General & Admin | $128.4K | $103.7K | $36.18K |
YoY Change | 228.63% | 228.73% | |
% of Gross Profit | 2054.88% | 1807.32% | 1134.17% |
Research & Development | $5.302K | $7.170K | |
YoY Change | 6785.71% | ||
% of Gross Profit | 92.45% | 224.76% | |
Depreciation & Amortization | $210.00 | $110.00 | |
YoY Change | |||
% of Gross Profit | 3.36% | 1.92% | |
Operating Expenses | $128.4K | $108.9K | $43.35K |
YoY Change | 244.67% | ||
Operating Profit | -$122.2K | -$103.2K | -$40.16K |
YoY Change | -2767.58% | 318.51% | |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $430.00 | $1.220K | |
YoY Change | |||
Pretax Income | -$121.8K | -$102.0K | -$40.15K |
YoY Change | 252.9% | 313.63% | |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$121.8K | -$102.0K | -$40.15K |
YoY Change | 252.9% | 313.59% | |
Net Earnings / Revenue | -1428.15% | -1307.18% | -892.22% |
Basic Earnings Per Share | $0.00 | $0.00 | |
Diluted Earnings Per Share | -$1.089K | -$913.50 | -$355.70 |
COMMON SHARES | |||
Basic Shares Outstanding | 111.7M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q3 | 2022 Q2 | 2021 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $106.3K | $197.2K | $214.0K |
YoY Change | -57.7% | -15.64% | |
Cash & Equivalents | $106.3K | $197.2K | $214.0K |
Short-Term Investments | |||
Other Short-Term Assets | $30.67K | ||
YoY Change | |||
Inventory | $33.26K | $35.08K | $39.98K |
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $170.3K | $232.3K | $254.0K |
YoY Change | -41.83% | -16.19% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $4.213K | $3.309K | |
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $4.213K | $3.309K | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $170.3K | $232.3K | $254.0K |
Total Long-Term Assets | $4.213K | $3.309K | $0.00 |
Total Assets | $174.5K | $235.6K | $254.0K |
YoY Change | -40.39% | -15.0% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.484K | $1.268K | $1.160K |
YoY Change | 42.69% | -12.55% | |
Accrued Expenses | $15.42K | $10.77K | |
YoY Change | 670.75% | 612.91% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $20.94K | $14.58K | $3.497K |
YoY Change | 588.88% | 392.57% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $20.94K | $14.58K | $3.497K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $20.94K | $14.58K | $3.497K |
YoY Change | 588.88% | 392.57% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$739.0K | -$617.2K | -$455.7K |
YoY Change | |||
Common Stock | $111.8K | $111.8K | $113.3K |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $153.5K | $221.0K | $250.5K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $174.5K | $235.6K | $254.0K |
YoY Change | -40.39% | -15.0% |
Cashflow Statement
Concept | 2022 Q3 | 2022 Q2 | 2021 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$121.8K | -$102.0K | -$40.15K |
YoY Change | 252.9% | 313.59% | |
Depreciation, Depletion And Amortization | $210.00 | $110.00 | |
YoY Change | |||
Cash From Operating Activities | -$106.2K | -$77.63K | -$38.36K |
YoY Change | 228.48% | 267.74% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$1.120K | -$3.420K | |
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$1.120K | -$3.420K | |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 16.50K | 113.5K | 1.000K |
YoY Change | -67.0% | -34.11% | |
NET CHANGE | |||
Cash From Operating Activities | -106.2K | -77.63K | -38.36K |
Cash From Investing Activities | -1.120K | -3.420K | |
Cash From Financing Activities | 16.50K | 113.5K | 1.000K |
Net Change In Cash | -90.85K | 32.45K | -37.36K |
YoY Change | -614.44% | -78.53% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$106.2K | -$77.63K | -$38.36K |
Capital Expenditures | -$1.120K | -$3.420K | |
Free Cash Flow | -$105.1K | -$74.21K | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001703157 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
usd | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
usd | |
CY2022Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2021Q2 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
usd | |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
usd | ||
CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2021Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
CY2021 | scth |
Cancellation Of Common Shares
CancellationOfCommonShares
|
usd | |
scth |
Cancellation Of Common Shares
CancellationOfCommonShares
|
usd | ||
us-gaap |
Depreciation
Depreciation
|
usd | ||
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
usd | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
usd | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-55927 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
SecureTech Innovations, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
WY | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
82-0972782 | ||
us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | ||
scth |
Stock Cancelled1
StockCancelled1
|
usd | ||
CY2022Q2 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
usd | |
CY2021Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
usd | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-06-30 | ||
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2355 Highway 36 West | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 400 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Roseville | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MN | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
55113 | ||
dei |
City Area Code
CityAreaCode
|
(651) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
317-8990 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.001 par value | ||
dei |
Trading Symbol
TradingSymbol
|
SCTH | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2022Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
111749800 | shares |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
197169 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
214026 | usd |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
35083 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
39975 | usd |
CY2022Q2 | us-gaap |
Assets Current
AssetsCurrent
|
232252 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
254001 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3309 | usd |
CY2022Q2 | us-gaap |
Assets
Assets
|
235561 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
254001 | usd |
CY2022Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1268 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1160 | usd |
CY2022Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
10765 | usd |
CY2022Q2 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
2547 | usd |
CY2021Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
2337 | usd |
CY2022Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
14580 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3497 | usd |
CY2022Q2 | us-gaap |
Liabilities
Liabilities
|
14580 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
3497 | usd |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
111749800 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
111749800 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
113336300 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
113336300 | shares |
CY2022Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
111750 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
113336 | usd |
CY2022Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
726474 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
592899 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-617243 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-455731 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
220981 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
250504 | usd |
CY2022Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
235561 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
254001 | usd |
CY2022Q2 | us-gaap |
Revenues
Revenues
|
7803 | usd |
CY2021Q2 | us-gaap |
Revenues
Revenues
|
9482 | usd |
us-gaap |
Revenues
Revenues
|
17153 | usd | |
us-gaap |
Revenues
Revenues
|
20532 | usd | |
CY2022Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
2068 | usd |
CY2021Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
2534 | usd |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
4690 | usd | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
5506 | usd | |
CY2022Q2 | us-gaap |
Gross Profit
GrossProfit
|
5735 | usd |
CY2021Q2 | us-gaap |
Gross Profit
GrossProfit
|
6948 | usd |
us-gaap |
Gross Profit
GrossProfit
|
12463 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
15026 | usd | |
CY2022Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
103647 | usd |
CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
31533 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
166238 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
49008 | usd | |
CY2022Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5302 | usd |
CY2021Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
77 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8952 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
77 | usd | |
CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
108949 | usd |
CY2021Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
31610 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
175190 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
49085 | usd | |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-103214 | usd |
CY2021Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-24662 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-162727 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-34059 | usd | |
CY2022Q2 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
1215 | usd |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
1215 | usd | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-101999 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24662 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-161512 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-34059 | usd | |
CY2022Q2 | scth |
Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
|
-0.00 | |
CY2021Q2 | scth |
Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
|
-0.00 | |
scth |
Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
|
-0.00 | ||
scth |
Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
|
-0.00 | ||
CY2022Q2 | scth |
Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
|
111657284 | shares |
CY2021Q2 | scth |
Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
|
170785937 | shares |
scth |
Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
|
112076577 | shares | |
scth |
Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
|
170615068 | shares | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
135967 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
222250 | usd |
CY2021Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.20 | |
CY2021 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
1000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-108713 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
250504 | usd |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
113501 | usd | |
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
18488 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-161512 | usd | |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
220981 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-161512 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-34059 | usd | |
us-gaap |
Depreciation
Depreciation
|
114 | usd | |
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
18488 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
4892 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
5594 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
108 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
115 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
10765 | usd | |
us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
210 | usd | |
us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
16 | usd | |
us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-126935 | usd | |
us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-28334 | usd | |
us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
3423 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3423 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
113501 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
172250 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
113501 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
172250 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-16857 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
143916 | usd | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
214026 | usd |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
89804 | usd |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
197169 | usd |
CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
233720 | usd |
scth |
Stock Cancelled1
StockCancelled1
|
1700 | usd | |
CY2021 | scth |
Discount Rate Minimum
DiscountRateMinimum
|
0.0016 | pure |
CY2021 | scth |
Discount Rate Maximum
DiscountRateMaximum
|
0.0021 | pure |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84A_eus-gaap--UseOfEstimates_zi0LpyMy8wJc" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.</p> <p style="font: 10pt Times New Roman; margin: 0"> </p> | ||
scth |
Warrants Disclosure
WarrantsDisclosure
|
<p id="xdx_802_ecustom--WarrantsDisclosure_zJDmeS9anSG7" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>NOTE 5 – WARRANTS</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The following table summarizes information with respect to outstanding warrants to purchase shares of the Company’s common stock as of June 30, 2022.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <table style="margin-left: auto; border-collapse: collapse; margin-right: auto"> <tr><td colspan="2" style="border-bottom: #000000 0.5pt solid; vertical-align: top; width: 100.55pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Price</b></p> </td><td style="vertical-align: top; width: 16.45pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p> </td><td style="border-bottom: #000000 0.5pt solid; vertical-align: top; width: 135pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Number</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Outstanding</b></p> </td><td style="vertical-align: top; width: 18pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p> </td><td style="border-bottom: #000000 0.5pt solid; vertical-align: top; width: 166.25pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Expiration</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: center"><b>Date</b></p> </td></tr> <tr><td style="border-top: #000000 0.5pt solid; vertical-align: top; width: 16.65pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p> </td><td style="border-top: #000000 0.5pt solid; vertical-align: top; width: 83.9pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td><td style="vertical-align: top; width: 16.45pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td><td style="border-top: #000000 0.5pt solid; vertical-align: top; width: 135pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td><td style="vertical-align: top; width: 18pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td><td style="border-top: #000000 0.5pt solid; vertical-align: top; width: 166.25pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td></tr> <tr><td style="vertical-align: top; background-color: #BDD6EE; width: 16.65pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: center">$</p> </td><td style="vertical-align: top; background-color: #BDD6EE; width: 83.9pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: right">0.50</p> </td><td style="vertical-align: top; background-color: #BDD6EE; width: 16.45pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td><td style="vertical-align: top; background-color: #BDD6EE; width: 135pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: right">439,300</p> </td><td style="vertical-align: top; background-color: #BDD6EE; width: 18pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td><td style="vertical-align: top; background-color: #BDD6EE; width: 166.25pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: center">December 31, 2022</p> </td></tr> <tr><td style="vertical-align: top; width: 16.65pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: center"> </p> </td><td style="vertical-align: top; width: 83.9pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td><td style="vertical-align: top; width: 16.45pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td><td style="border-top: #000000 0.5pt solid; border-bottom: #000000 3px double; vertical-align: top; width: 135pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: right">439,300</p> </td><td style="vertical-align: top; width: 18pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td><td style="vertical-align: top; width: 166.25pt; padding-left: 5.4pt; padding-right: 5.4pt"><p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> </td></tr> </table> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"><i>Warrant Issuances, Exercises, and Expirations</i></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">Private Placement Warrant Issuances</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">During the fiscal year ended December 31, 2020, the Company undertook a private placement of its securities through a private placement Unit offering. Each Unit included one share of the Company's common stock and four stock purchase warrants with incremental exercise prices and expiration dates. An aggregate of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20201231_znCgMm136vD4">1,757,200</span> stock purchase warrants were issued under this offering, which was closed on June 30, 2020.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">The warrants were valued using the Black-Scholes model with a <span id="xdx_905_eus-gaap--AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherFairValueVolatilityRate_dp_c20210101__20211231_z9hbeSDCjadf">53.0</span>% volatility rate and discount rates ranging from <span id="xdx_90C_ecustom--DiscountRateMinimum_dp_c20210101__20211231_zsppzPkAKnYd">0.16%</span> - <span id="xdx_900_ecustom--DiscountRateMaximum_dp_c20210101__20211231_zzFmElUVVg4l">0.21</span>% for a total fair value of $<span id="xdx_906_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20211231_zZMdlVCuKSd7">19,257</span>.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">Warrant Expirations</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000">During the fiscal period ended June 30, 2022, an aggregate of 878,600 warrants expired with an average exercise price of $0.35 a share.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify; color: #000000"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">A summary of the warrant activity for the fiscal period ended June 30, 2022, is as follows:</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based on warrants with an exercise price less than the Company’s stock price of $1.75 (based on the bid price quoted on the OTC Pink Tier of the OTC Market Group, Inc.) as of June 30, 2022, which the warrant holders would have received had those warrant holders exercised their warrants as of that date.</p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> | ||
CY2020Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
1757200 | shares |
CY2021 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Other Fair Value Volatility Rate
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherFairValueVolatilityRate
|
0.530 | pure |
CY2021Q4 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
19257 | usd |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1500000 | shares |
us-gaap |
Fiscal Period
FiscalPeriod
|
<p id="xdx_846_eus-gaap--FiscalPeriod_zVxUpyA1uwva" style="font: 10pt Times New Roman; margin: 0; text-align: justify"><b>Fiscal Year</b></p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0; text-align: justify">The Company elected December 31st for its fiscal year-end.</p> <p style="font: 10pt Times New Roman; margin: 0"> </p> | ||
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-617243 | usd |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.35 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
3.160 | pure | |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
113500 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
|
0.028 | pure | |
CY2022Q2 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
1754 | usd |
CY2021Q4 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
1955 | usd |
CY2022Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
33329 | usd |
CY2021Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
38020 | usd |
CY2022Q2 | us-gaap |
Inventory Gross
InventoryGross
|
35083 | usd |
CY2021Q4 | us-gaap |
Inventory Gross
InventoryGross
|
39975 | usd |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
35083 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
39975 | usd |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
1.00 | |
us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
1700000 | shares | |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
111749800 | shares |
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
18488 | usd | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P10Y6M | ||
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1500000 | shares |